Culture carrier, medium, cell cluster production method and method for producing culture carrier
A culture carrier using fishmeal-derived fishmeal, produced by processing fish bodies into a culture medium, addresses the limitations of fish scale collagen for animal cell culture, enhancing cell proliferation and biocompatibility.
Patent Information
- Application Number
- JP2024038479
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-18
- Filing Date
- 2024-03-12
- Publication Date
- 2024-11-28
AI Technical Summary
Collagen derived from fish scales is unsuitable for animal cell culture at 37°C due to low denaturation temperature and potential biocompatibility issues, and its extraction process is complicated.
A method involving the production of a culture carrier using fishmeal, which includes steps of removing fish heads and internal organs, drying, crushing, sterilizing, and further drying to create a culture carrier containing fishmeal, which is used to culture cell masses.
The method provides a practical culture carrier and medium for producing cell clusters, enhancing cell proliferation and maintaining biocompatibility, with improved efficiency and cost-effectiveness.
Smart Images

Figure 2024166078000001 
Figure 2024166078000002 
Figure 2024166078000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a culture support, a medium, a method for producing a cell aggregate, and a method for producing a culture support. [Background technology]
[0002] Mass culture of animal cells plays an important role in the production of medicines, foods, cosmetics, etc. Various researches on this mass culture method are being conducted around the world. Tanks and bioreactors are used for mass culture. In particular, bioreactors circulate the culture medium and control the flow of the medium, making it possible to culture cells at high cell densities. It is known that there is a close correlation between cell density and cell proliferation, and increasing cell density is the most important issue in mass culture. By adding culture carriers derived from collagen or plastic beads to a normal culture medium, the cells are adjusted to maintain a suspended state in the culture solution while remaining attached to the carrier to which the cells have been added.
[0003] Traditionally, collagen and plastic-based materials have been widely used as culture carriers. Collagen is a major protein present in many animal tissues, and is found in various tissues such as skin, bone, cartilage, tendons, ligaments, blood vessels, and teeth. This collagen is composed of three polypeptide chains that form a left-handed helical structure. In particular, collagen is one of the main components of the extracellular matrix (ECM), and exists between cells to regulate adhesion and function. Animal-derived (bovine, porcine, and murine) collagen is very expensive, costing about 40,000 yen per 100 ml, due to the complicated extraction process.
[0004] In contrast, collagen derived from fish is somewhat cheaper than collagen derived from animals. Fish scales are also used as a source of collagen (see, for example, Patent Document 1). [Prior art documents] [Patent documents]
[0005] [Patent Document 1] Patent No. 6165103 Summary of the Invention [Problem to be solved by the invention]
[0006] Collagen derived from fish scales is used industrially, primarily in cosmetics. However, the denaturation temperature of collagen derived from fish scales is low, at around 27°C, making it unsuitable for use with animal cells cultured at 37°C due to the denaturation of the material. Collagen derived from fish scales can be used by chemically crosslinking it, but there is concern that crosslinking treatment may reduce biocompatibility. Thus, the process of extracting collagen from fish scales remains cumbersome. The present invention has been made in consideration of the above circumstances, and provides a culture carrier, a culture medium, a method for producing a cell aggregate, and a method for producing a culture carrier, which are highly practical. [Means for solving the problem]
[0007] The present invention includes the following aspects. [1] A cultivation carrier for culturing cell masses, comprising fish meal. [2] A culture medium for culturing cell masses, comprising the culture carrier according to [1]. [3] A method for producing a cell mass, comprising culturing cells in the medium according to [2]. [4] A method for producing a culture carrier for forming cell aggregates, comprising a grinding step of grinding dried fish body or dried fish meat to obtain fish meal. [5] The method for producing a culture carrier according to [4], further comprising a removal step of removing the head and / or viscera from the fish body to obtain fish meat. [6] The method for producing a culture support according to [4], further comprising a drying step of drying the fish body or fish meat to obtain a dried fish body or a dried fish meat. [7] The method for producing a cultivation support according to [4], further comprising a sterilization step of sterilizing the fish meal. [8] The method for producing a cultivation support according to [7], further comprising a drying step of drying the sterilized fish meal. Effect of the Invention
[0008] According to the present invention, it is possible to provide a culture carrier, a culture medium, a method for producing a cell aggregate, and a method for producing a culture carrier, which are highly practical. [Brief description of the drawings]
[0009] [Figure 1] This paper presents histological characteristics of various commercially available dried fish and dried fish scaffolds (DFS) made from live fish. [Diagram 2] Photographs showing the formation treatment on surviving individuals. [Diagram 3] Photographs showing the preparation of dried bodies from the fish body samples after formation and the crushing process. [Figure 4] 1 shows photographs depicting the changes over time in human epidermal cell spheroids cultured using dried fish meal. [Diagram 5] 13 is a set of photographs showing the changes over time in mouse fibroblast spheroids cultured using dried fish meal. [Figure 6] 1 shows photographs showing the cell morphology of various cell spheroids cultured using dried fish meal. [Figure 7] 1 shows photographs showing the cell morphology of various cell spheroids cultured using dried fish meal. [Figure 8] 13 is a photograph showing a Ki67 immunostained image of human epidermal cells on the first day of culture using dried fish meal. [Figure 9] 13 is a photograph showing a Ki67 immunostained image of human epidermal cells on the third day of culture in a serum-free medium using dried fish meal. [Figure 10](A) Photograph showing organization of cell spheroids by HaCaT cells on day 1. (B) Photograph showing organization of cell spheroids by HaCaT cells on day 3. (C) Photograph showing HaCaT cell spheroids stained with cell proliferation marker Ki67. (D) Photograph showing HaCaT cell spheroids stained with cytokeratin markers CK AE1 / AE3. (E) Photograph showing organization of cell spheroids by NIH / 3T3 cells on day 3. (F) Photograph showing NIH / 3T3 cell spheroids stained with cell proliferation marker PCNA. (G) Photograph showing NIH / 3T3 cell spheroids stained with myofibroblast marker αSMA. Arrows indicate myofibroblasts. (H) Photograph showing organization of cell spheroids by MS-1 cells on day 3. (I) Photograph showing organization of cell spheroids by HMY-1 cells on day 3. (J) Photographs showing organization of cell spheroids by CAF cells on day 7. (K) Photographs showing organization of cell spheroids by HaCaT cells and NIH / 3T3 cells on day 3. (L) Photographs showing spheroids of HaCaT cells and NIH / 3T3 cells stained with cytokeratin markers CK AE1 / AE3. Arrows indicate CK AE1 / AE3-negative NIH / 3T3 cells. (AL) Bar = 50 μm. [Figure 11] (A) Expression levels of MAPK family proteins, ERK1 / 2, p-ERK1 / 2, p38, and p-p38 in spheroids of HaCaT cells (n=4) or NIH / 3T3 cells (n=4) were evaluated by Western blotting. PD: plastic dish. DFS: dried fish meal. (B) Quantification results in HaCaT cells in (A). Relative expression is expressed as the ratio of target protein expression to α / β-tubulin expression. PD: plastic dish. DFS: dried fish meal. (C) Quantification results in NIH / 3T3 cells in (A). Relative expression is expressed as the ratio of target protein expression to α / β-tubulin expression. PD: plastic dish. DFS: dried fish meal. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Hereinafter, an embodiment of the present invention will be described in detail, with reference to the drawings if necessary.
[0011] <<Method for producing a culture carrier for forming cell aggregates>> In one embodiment, the present invention provides a method for producing a culture carrier for forming cell aggregates, comprising a grinding step of grinding a dried fish body or a dried fish meat body to obtain fish meal. Preferably, the method for producing the culture carrier of this embodiment includes step 1 of removing the head and viscera from the fish body to obtain fish meat, step 2 of drying the fish meat to obtain dried fish meat, step 3 of grinding the dried fish meat to obtain fish meal, step 4 of sterilizing the fish meal, and step 5 of drying the sterilized fish meal.
[0012] In this specification, a cell mass refers to a three-dimensional structure composed of multiple cells. Examples of cell masses include spheroids and organoids. Organoids are complex clusters of organ-specific cells derived from organs such as the stomach, liver, and bladder. Spheroids are simple clusters of a wide variety of cells, including tumor tissue, embryoid bodies, hepatocytes, neural tissue, and cells derived from the mammary gland.
[0013] Step 1 is a step of removing the head and viscera from the fish body to obtain fish meat. The fish body is not particularly limited as long as it is a fish, and examples thereof include cod, tuna, salmon, trout, bonito, flounder, yellowtail, shark, ray, sardine, horse mackerel, Atka mackerel, and killifish, and killifish is preferred from the viewpoints of its strong vitality and ease of breeding. From the viewpoint of eliminating endotoxins derived from attached bacteria, the head and viscera are removed from the fish body. Furthermore, it is preferable to fillet the fish into three pieces and use the right and left pieces as fish meat.
[0014] Step 2 is a step of drying the fish meat to obtain dried fish meat. The drying method is not particularly limited, but vacuum drying is preferable from the viewpoint of increasing drying efficiency. As an example of drying efficiency, if the weight of the fish meat before drying is 0.66 to 0.86 g per 10 medaka, it is dried so that the weight becomes 0.15 to 0.32 g per 10 medaka.
[0015] Step 3 is a step of crushing the dried fish meat to obtain fish meal. The crushing method is not particularly limited, but it is preferable to use a crusher in order to increase the crushing efficiency. Dried fish may be used as the dried fish meat to be crushed. Dried fish is easily available all over the world and contains a large amount of collagen because it is composed of skin and muscle tissue. In other words, dried fish is a dried collagen body and can be used as a scaffold material to enhance the function of cultured cells. Furthermore, even if dried fish is roasted, the phenomenon of collagen dissolving is not observed. Based on this knowledge, the inventor came up with the idea of a biomanufacturing system that uses dried fish meat as a new culture carrier to efficiently and inexpensively produce high-value-added animal protein with modifications such as sugar chains and lipids.
[0016] Step 4 is a step of sterilizing the fish meal. The sterilization method is not particularly limited, but alcohol sterilization is preferable, and ethanol sterilization is more preferable.
[0017] Step 5 is a step of drying the sterilized fish meal. The drying method is not particularly limited, but drying using an evaporator is preferred.
[0018] <Culture carrier> In one embodiment, the present invention provides a cultivation support for culturing cell masses, the cultivation support containing fish meal.
[0019] An example of the method for producing the culture carrier of this embodiment is the above-mentioned <<Production method of the culture carrier for forming cell aggregates>>, but is not particularly limited thereto. From the viewpoint of eliminating endotoxins derived from adhering bacteria, the fish meal contained in the culture carrier of this embodiment is preferably a powder of dried fish meat from which the head and internal organs have been removed, and it is even more preferable that it has been sterilized and dried.
[0020] The fish meal contained in the culture carrier of this embodiment contains collagen. Examples of collagen include collagen type 1, type 2, type 3, type 4, type 5, and type 11. The fish meal may also contain glycosaminoglycan, hyaluronic acid, proteoglycan, gelatin, etc. It is also preferable that the fish meal is dehydrated by sterilization with ethanol to reconstitute the proteins contained in the fish meal. Furthermore, the fish meal may contain proteins involved in muscle contraction, such as myosin and actin.
[0021] Culture medium In one embodiment, the present invention provides a medium for culturing a cell mass comprising a culture carrier. The culture carrier is as described in the section "Culture carrier".
[0022] The basal medium is not particularly limited, and may be any medium commonly used in animal culture, including, for example, IMDM medium, Medium 199 medium, Eagle's Minimum Essential Medium (EMEM) medium, αMEM medium, Dulbecco's Modified Eagle's Medium (DMEM) medium, Ham's F12 (F12) medium, RPMI 1640 medium, Fischer's medium, and mixtures thereof. The medium may contain serum (e.g., fetal bovine serum (FBS)) or may be serum-free. If necessary, it may contain serum substitutes such as albumin, transferrin, KnockOut Serum Replacement (KSR) (serum substitute for ES cell culture) (Invitrogen), N2 supplement (Invitrogen), B27 supplement (Invitrogen), fatty acids, insulin, collagen precursors, trace elements, 2-mercaptoethanol, 3'-thiolglycerol, etc. It may also contain substances such as lipids, amino acids, L-glutamine, GlutaMAX (Invitrogen), non-essential amino acids (NEAA), vitamins, growth factors, antibiotics, antioxidants, pyruvic acid, buffers, inorganic salts, and the like.
[0023] ≪Cell mass production method≫ In one embodiment, the present invention provides a method for producing a cell mass, in which cells are cultured in a medium. The medium is as described in "Medium".
[0024] The manufacturing method of this embodiment will be described in detail below. First, a medium in which cells are suspended is prepared. Then, this suspension is poured into a culture dish. Then, the cells in this cell culture dish are cultured, for example, in a humidified 5% CO2 incubator at a temperature of 37°C. Cells are cultured for 1 to 10 days, preferably 3 to 5 days, to form cell clusters.
[0025] Examples of cells used in the manufacturing method of this embodiment include vertebrate cells such as mammalian cells, avian cells, reptile cells, amphibian cells, and fish cells; and invertebrate cells such as insect cells, crustacean cells, mollusc cells, and protozoan cells.
[0026] Examples of vertebrate cells (particularly mammalian cells) include, but are not limited to, germ cells (sperm, eggs, etc.), somatic cells constituting an organism, stem cells, progenitor cells, cancer cells isolated from an organism, cells (cell lines) isolated from an organism and acquired immortalization ability and stably maintained outside the body, cells isolated from an organism and artificially genetically modified, cells isolated from an organism and artificially exchanged nuclei, etc. Also, small tissue pieces isolated from normal tissues or cancer tissues of an organism may be used as they are.
[0027] Examples of somatic cells that constitute a living organism include, but are not limited to, cells collected from any tissue such as skin, kidney, spleen, adrenal gland, liver, lung, ovary, pancreas, uterus, stomach, colon, small intestine, large intestine, bladder, prostate, testis, thymus, muscle, connective tissue, bone, cartilage, vascular tissue, blood, heart, eye, brain, and nervous tissue. More specific examples of somatic cells include, but are not limited to, fibroblasts, bone marrow cells, immune cells (e.g., B lymphocytes, T lymphocytes, neutrophils, macrophages, monocytes, etc.), red blood cells, platelets, bone cells, bone marrow cells, pericytes, dendritic cells, epidermal keratinocytes, adipocytes, mesenchymal cells, epithelial cells, epidermal cells, endothelial cells, vascular endothelial cells, lymphatic endothelial cells, hepatic cells, pancreatic islet cells (e.g., α cells, β cells, δ cells, ε cells, PP cells, etc.), chondrocytes, cumulus cells, glial cells, nerve cells (neurons), oligodendrocytes, microglia, astrocytes, cardiac muscle cells, esophageal cells, muscle cells (e.g., smooth muscle cells, skeletal muscle cells, etc.), melanocytes, mononuclear cells, and the like.
[0028] Stem cells are cells that have the ability to replicate themselves and differentiate into cells of multiple lineages. Examples of stem cells include, but are not limited to, embryonic stem cells (ES cells), embryonic tumor cells, embryonic germline stem cells, induced pluripotent stem cells (iPS cells), neural stem cells, hematopoietic stem cells, mesenchymal stem cells, hepatic stem cells, pancreatic stem cells, muscle stem cells, germline stem cells, intestinal stem cells, cancer stem cells, and hair follicle stem cells.
[0029] A precursor cell is a cell that is at an intermediate stage in the differentiation of the stem cell into a specific somatic cell or germ cell.
[0030] Cancer cells are cells that derive from somatic cells and acquire the ability to proliferate indefinitely, and are malignant neoplasms that invade surrounding tissues or cause metastasis. Examples of cancers from which cancer cells originate include breast cancer (e.g., invasive ductal carcinoma, non-invasive ductal carcinoma, inflammatory breast cancer, etc.), prostate cancer (e.g., hormone-dependent prostate cancer, hormone-independent prostate cancer, etc.), pancreatic cancer (e.g., pancreatic ductal carcinoma, etc.), gastric cancer (e.g., papillary adenocarcinoma, mucinous adenocarcinoma, adenosquamous carcinoma, etc.), lung cancer (e.g., non-small cell lung cancer, small cell lung cancer, malignant mesothelioma, etc.), colon cancer (e.g., gastrointestinal stromal tumor, etc.), rectal cancer (e.g., gastrointestinal stromal tumor, etc.), colorectal cancer (e.g., For example, familial colorectal cancer, hereditary nonpolyposis colorectal cancer, gastrointestinal stromal tumor, etc.), small intestine cancer (for example, non-Hodgkin's lymphoma, gastrointestinal stromal tumor, etc.), esophageal cancer, duodenal cancer, tongue cancer, pharyngeal cancer (for example, nasopharyngeal cancer, oropharyngeal cancer, hypopharyngeal cancer, etc.), head and neck cancer, salivary gland cancer, brain tumors (for example, pineal astrocytoma, pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, etc.), neurilemmoma, liver cancer (for example, primary liver cancer, extrahepatic bile duct cancer, etc.), kidney cancer (for example, renal cell carcinoma, transitional cell carcinoma of the renal pelvis and ureter, etc.), gallbladder cancer, pancreatic cancer, endometrial cancer, cervical cancer, ovarian cancer (e.g., epithelial ovarian cancer, extragonadal germ cell tumor, ovarian germ cell tumor, ovarian low malignant potential tumor, etc.), bladder cancer, urethral cancer, skin cancer (e.g., intraocular (eye) melanoma, Merkel cell carcinoma, etc.), hemangioma, malignant lymphoma (e.g., reticulum cell sarcoma, lymphosarcoma, Hodgkin's disease, etc.), melanoma, thyroid cancer (e.g., medullary thyroid carcinoma, etc.), parathyroid cancer, nasal cavity cancer, paranasal sinus cancer, bone tumors (e.g., Examples of cancers that may be present include, but are not limited to, osteosarcoma, Ewing's tumor, uterine sarcoma, soft tissue sarcoma, metastatic medulloblastoma, angiofibroma, dermatofibrosarcoma protuberans, retinal sarcoma, penile cancer, testicular tumor, pediatric solid tumors (e.g., Wilms' tumor, pediatric renal tumor, etc.), Kaposi's sarcoma, Kaposi's sarcoma caused by AIDS, maxillary sinus tumor, fibrous histiocytoma, leiomyosarcoma, rhabdomyosarcoma, chronic myeloproliferative disorder, leukemia (e.g., acute myeloid leukemia, acute lymphoblastic leukemia, etc.), and the like.
[0031] A cell line is a cell that has acquired infinite proliferation ability by artificial manipulation outside the body. Examples of cell lines include, but are not limited to, HCT116, Huh7, HEK293 (human fetal kidney cells), HeLa (human cervical cancer cell line), HepG2 (human liver cancer cell line), UT7 / TPO (human leukemia cell line), CHO (Chinese hamster ovary cell line), MDCK, MDBK, BHK, C-33A, HT-29, AE-1, 3D9, Ns0 / 1, Jurkat, NIH3T3, PC12, S2, Sf9, Sf21, High Five, Vero, etc.
[0032] The cells in the cell culture dish bind to the fish meal and grow to form cell clumps. EXAMPLES
[0033] The present invention will be described below with reference to examples, but the present invention is not limited to the following examples.
[0034] [Production Example 1] Histopathological evaluation of dried fish meal prepared using commercially available dried fish and live fish (1) Sample Dried fish meal (Dried fish scaffold: DFS) made from commercially available whole dried sardines, Japanese anchovies (boiled and dried), horse mackerel (dried fish), Atka mackerel (dried overnight), Japanese flying squid (dried squid), and live individuals (Medaka killifish) were used (see Production Example 2 for the production method). (2) Histopathological evaluation The above samples were fixed in formalin for 48 hours, embedded in paraffin, and then sliced. Cell morphology was evaluated by hematoxylin-eosin (HE) staining, which is commonly used in histopathological diagnosis. Analysis of collagen fibers and muscle tissue was performed by Azan staining, and evaluation of elastic fibers and collagen fibers in connective tissue fibers was performed by Elastica van Gieson (EVG) staining. Evaluation of types 1 and 3 collagen was performed using Picrosirius Red (PSR) stained specimens under a polarizing microscope. The results are shown in Figure 1.
[0035] In commercially available dried fish and mollusks, the degree of degeneration in the cells and extracellular matrix that make up the tissues varied greatly depending on the raw organism and manufacturing method (see Figure 1). In particular, in the case of dried sardines using the whole drying method, the nuclei of the cells that make up the tissues had completely disappeared when observed with HE staining, and the striated structure in the muscle tissue had also disappeared. In analyses with Azan staining and EVG staining, most elastic fibers could not be confirmed. When type 1 and type 3 collagen were examined by PSR staining, no orange or green polarized images were observed, suggesting that the aforementioned collagen had been decomposed and gelatinized.
[0036] On the other hand, in the case of the sardine method, the nuclear structure stained basophilically was maintained in HE staining, and the striated structure was also identifiable. In addition, elastic fibers were observed between muscle fibers in EVG staining. Type 1 collagen, which was orange, and type 3 collagen, which was green, were confirmed in PSR staining. The nuclear structure and elastic fibers were preserved in the dried squid method, and PSR staining confirmed that types 1 and 3 collagen were preserved in the tissue. In the DFS prepared using the Minami-Medaka, the nuclear structure stained basophilic was maintained by HE staining, and the striated structure was also identifiable. EVG staining confirmed elastic fibers present between muscle fibers. PSR staining confirmed type 1 collagen, which was orange, and type 3 collagen, which was green.
[0037] [Production Example 2] Preparation of dried fish meal using dried fish and live fish (1) Forming process DFS was prepared using commercially available whole dried sardines, Japanese anchovies (boiled and dried), horse mackerel (dried fish), Atka mackerel (dried overnight), Japanese flying squid (dried squid), and live individuals (Minami medaka). For live individuals, after treatment with antibiotic-containing water, the head and internal organs were removed, and the abdomen was cut into three pieces (see Figure 2). For dried fish, the head and internal organs were removed as much as possible to prepare samples. Minami medaka was used as the live individual. (2) Preparation of dried bodies and crushing process The fish body samples after formation were dried for about 20 hours using a vacuum dryer. The weight after drying was reduced to about 1 / 5 of the weight before drying. The dried samples were then crushed using a crusher (Force Mill manufactured by Kenis Co., Ltd.). The crushed samples were again subjected to vacuum drying for 20 hours (see Figure 3). (3) Alcohol fixation and dehydration The ground material was soaked in 80% ethanol and dehydrated and fixed in a -30℃ freezer for 48 hours.The ethanol was then removed using an evaporator (room temperature, 20 minutes) to produce the desired dried fish meal (DFS).
[0038] [Example 1] Analysis of the viability and proliferation of mammalian cultured cells using dried fish meal (1) Cells and culture medium used Cell lines: human epidermal cell line (HaCaT), mouse fibroblasts (NIH-3T3, provided by JCRB Cell Bank), mouse vascular endothelial cells (MS-1, provided by ATCC), malignant melanoma cell line (KHm1, provided by JCRB Cell Bank) Culture medium: 10% fetal bovine serum (Nichirei Biosciences) + RPMI-1640 (Fujifilm Wako Pure Chemical Industries) + penicillin-streptomycin solution (Fujifilm Wako Pure Chemical Industries)
[0039] (2)Culture method 5-10mg of DFS and 500,000-1,000,000 cultured cells were mixed in 4ml of medium and left to stand for 4 hours. After that, 2ml of the mixture of DFS and cells was dispensed into 10cm culture dishes containing 10ml of medium. The culture dishes were rotated at 25-30rpm using a rotary shaker. (3) Fixation and specimen preparation After the start of the culture, cell samples that had formed spheroids were collected on days 1 to 5, and pathological specimens were prepared using the cell block method used for preparing specimens in cytological diagnosis.
[0040] (4) Staining and immunostaining Morphological evaluation was performed using hematoxylin and eosin (HE) staining, and cell proliferation was analyzed using immunostaining for Ki67 and PCNA.
[0041] (5) Effect of DFS on mammalian cells In DFS using commercially available dried fish, the survival rate of various mammalian cells was low even after short-term culture. Although no clear bacterial infection was observed, the involvement of endotoxin (lipopolysaccharide) derived from attached bacteria was suggested. In the following examples, by using live individuals, sterilization was performed quickly while minimizing bacterial proliferation.
[0042] DFS derived from surviving Minami-Medaka individuals were used in co-culture with human epidermal cells (HaCaT), mouse fibroblasts (NIH-3T3), mouse vascular endothelial cells (MS-1), and malignant melanoma cells (KHm1). All cells adhered to the DFS, and spheroid formation was observed after 5 hours (see Figure 4-5).
[0043] Human epidermal cells (HaCaT), mouse fibroblasts (NIH-3T3), mouse vascular endothelial cells (MS-1), and malignant melanoma cells (KHm1) were observed to adhere and grow on DFS, which showed eosinophilicity in HE staining. Cell block analysis showed no signs of vacuolar degeneration or nuclear pyknosis / disintegration, which would suggest cell injury, until the third day of culture (see Figures 6-7).
[0044] To confirm the proliferation ability of the cells, the expression of the cell proliferation marker Ki67 protein was confirmed using immunostaining. As a result, more than 80% of the human epidermal cells on the first day of culture showed Ki67 positive images, indicating the presence of active proliferation ability (see Figure 8). In cell cultures using DFS derived from living individuals, no bacterial infection was observed during the culture period.
[0045] [Example 2] Analysis of the survival and proliferation ability of human epidermal cells in serum-free medium using dried fish meal Human epidermal cells (HaCaT cells) were seeded on DFS to prepare cell spheroids, which were then cultured for 3 days using serum-free medium. The control group was cultured using normal RPMI-1640 medium (containing penicillin and streptomycin) containing 10% serum. After formalin fixation, cell proliferation was evaluated by immunostaining for Ki67. The results are shown in Figure 9.
[0046] When cultured in serum-containing medium, HaCaT cells showed more than 80% positive images for Ki67, a cell proliferation marker. In serum-free culture groups, approximately 30% of HaCaT cells with identifiable nuclei showed positive images for Ki67. It was confirmed that serum-free culture for at least 3 days is possible when cell spheroids are produced using DFS.
[0047] [Example 3] Histological analysis of cell spheroids using DFS Histological analysis was performed on cell spheroid types generated using DFS. The results are shown in Figure 10. On the first day of culture, HaCaT cells effectively attached to the DFS surface and maintained viability. We also noted areas of the DFS that were not covered with cells. By the third day of culture, a significant portion of the DFS surface within the spheroids was surrounded by cells. The Ki67 labeling index, a marker of cell proliferation in HaCaT cells, was observed to be 86.3 ± 3.4% on day 3. Furthermore, immunostaining showed positive pancytokeratin (CK AE1 / AE3) in HaCaT cells derived from epidermal tissue. On the third day of culture, NIH / 3T3 cells proliferated and covered the surface of the DFS. The labeling index by immunostaining using PCNA, a marker of cell proliferation, was 93.0 ± 2.1%. Furthermore, immunostaining with αSMA showed that only a small proportion of cells differentiated into myofibroblasts, and the majority of NIH / 3T3 cells were negative for αSMA. Both MS-1 cells, an endothelial cell line, and HMY-1 cells, a malignant melanoma cell line, adhered to DFS and survived for 3 days. On day 7 of culture, CAF cells showed proliferation on the DFS surface, and characteristic structures with numerous DFS bound to them were observed. Cell spheroids also grew in co-cultures of HaCaT cells and NIH / 3T3 cells using DFS. Interestingly, although most spheroids were composed primarily of a single cell type, some showed a mosaic composition of different cell types.
[0048] [Example 4] Protein expression in cell spheroids using DFS Protein expression in cells cultured using DFS was compared with that in cells cultured on regular plastic dishes. In this study, we evaluated ERK and p38, which are components of the mitogen-activated protein kinase (MAPK) signaling pathway that plays an important role in regulating cell proliferation and differentiation (see Figure 11). No significant difference was observed in the expression levels of total ERK1 / 2 between HaCaT cells cultured with DFS (DFS-HaCaT group) and HaCaT cells cultured on normal plastic dishes (PD-HaCaT group). However, the phosphorylation rate of ERK1 / 2 was significantly higher in the DFS-HaCaT group compared with the PD-HaCaT group. The expression ratio of total p38 was significantly higher in the DFS-HaCaT group, and the phosphorylation rate was significantly higher in the DFS-HaCaT group compared with the PD-HaCaT group. In NIH / 3T3 cells, no significant difference was observed in the total ERK1 / 2 expression levels between cells cultured on plastic dishes (PD-NIH / 3T3 group) and cells cultured with DFS (DFS-NIH / 3T3 group). However, the phosphorylation rate of ERK1 / 2 was significantly lower in the DFS-NIH / 3T3 group compared with the PD-NIH / 3T3 group. There was no significant difference in the expression level of total p38 between the DFS-NIH / 3T3 group and the PD-NIH / 3T3 group, and the phosphorylation rate of p38 was significantly higher in the DFS-NIH / 3T3 group. [Industrial Applicability]
[0049] According to the present invention, it is possible to provide a culture carrier, a culture medium, a method for producing a cell aggregate, and a method for producing a culture carrier, which are highly practical.
Claims
1. A culture carrier for culturing cell masses, comprising fish meal.
2. A culture medium for culturing cell clusters, comprising the culture carrier according to claim 1.
3. A method for producing a cell mass, comprising culturing cells in the medium according to claim 2.
4. A method for producing a culture carrier for forming cell aggregates, comprising a grinding step of grinding a dried fish body or a dried fish meat body to obtain fish meal.
5. The method for producing a culture carrier according to claim 4, further comprising a removing step of removing a head and / or an organ from the fish body to obtain fish meat.
6. The method for producing a culture carrier according to claim 4, further comprising a drying step of drying the fish body or fish meat to obtain a dried fish body or a dried fish meat.
7. The method for producing a cultivation carrier according to claim 4, further comprising a sterilization step of sterilizing the fish meal.
8. The method for producing a cultivation support according to claim 7, further comprising a drying step of drying the sterilized fish meal.
Citation Information
Patent Citations
Measuring instrument
JP1986065103A
